Verve Therapeutics
Verena Karsten is the senior director, clinical research at Verve Therapeutics. She has over 20 years’ experience in clinical development. Prior to joining Verve, she worked at Vion Pharmaceuticals, Alnylam Pharmaceuticals and CRISPR Therapeutics. Verena received her Diploma and Ph.D. in biology from the Free University in Berlin.
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.